Comments

Celldex Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Celldex Therapeutics (CLDX) operate in?

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CLDXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Celldex Therapeutics (CLDX) Forecast

News Earnings Celldex Therapeutics (CLDX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Celldex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CLDX | Benzinga

Explore Celldex Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CLDX.

Open	$19.83
Close	-
Volume / Avg.	171.56K / 853.09K
Day Range	$19.51 - $20.19
52 Wk Range	18.61 - 47.00
Market Cap	$1.31B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	15.94%
Days to Cover	11.19

Recent News

This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Baidu, Informatica And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors

Jasper Therapeutics reports strong briquilimab efficacy in CSU with UAS7 reductions, dose-dependent responses, and Phase 2b plans by late 2025.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$19.83
Close	-
Volume / Avg.	171.56K / 853.09K
Day Range	$19.51 - $20.19
52 Wk Range	18.61 - 47.00
Market Cap	$1.31B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	15.94%
Days to Cover	11.19

About Celldex Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commer...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Celldex Therapeutics (CLDX) stock?

You can purchase shares of Celldex Therapeutics (NASDAQ:CLDX) through any online brokerage.

View our list of the best stock brokerages

Who are Celldex Therapeutics (CLDX) competitors?

Other companies in Celldex Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Ascentage Pharma Group (NASDAQ:AAPG) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Celldex Therapeutics (CLDX) stock?

Celldex Therapeutics has a consensus price target of $60.70.

What is the current price for Celldex Therapeutics (CLDX)?

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $19.75 last updated March 28, 2025 at 3:07 PM EDT.

Does Celldex Therapeutics (CLDX) pay a dividend?

There are no upcoming dividends for Celldex Therapeutics.

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

Celldex Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is Celldex Therapeutics (CLDX) going to split?

There is no upcoming split for Celldex Therapeutics.

What sector and industry does Celldex Therapeutics (CLDX) operate in?

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.